Doctor profile · Federal record
Dr. James Edmondson, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Indianapolis, IN
- NPI 1831154863
- Accepts Medicare
- 57 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
100 Hospital Ln, Suite 205
Indianapolis, IN 462025112
(317) 745-7445
fax (317) 745-7449 - Mailing address
-
1100 Southfield Dr, Suite 1370
Plainfield, IN 461684498
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- March 4, 2021
- Year of graduation
- 1969 — 57 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Indiana #01022719
- Medicaid
- IN #100277890
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1831154863. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,734
Distinct HCPCS
7
Medicare allowed
$164,150
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 3,720 | 39 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 443 | 237 | $119 | |
83036 |
Hemoglobin a1c level | 294 | 146 | $9 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 101 | 100 | $83 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 84 | 84 | $153 | |
96372 |
Injection of drug or substance under skin or into muscle | 81 | 43 | $13 | |
82044 |
Urine microalbumin (protein) analysis | 11 | 11 | $6 |
In context: peer comparison
Among 14 peers in Indianapolis Endocrinology, Diabetes & Metabolism Physician, average services per provider: 195. This provider delivers 24× the peer median.Open Payments
Industry payments received
All-time total
$2,422
Transactions
141
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 32 | $424.26 | |
| Novo Nordisk INC | 23 | $360.01 | |
| Lilly USA, LLC | 14 | $207.46 | |
| Xeris Pharmaceuticals, INC. | 10 | $200.20 | |
| Radius Health, INC. | 10 | $180.58 | |
| Insulet Corporation | 9 | $163.36 | |
| Sanofi-Aventis U.S. LLC | 7 | $152.24 | |
| Novartis Pharmaceuticals Corporation | 9 | $136.63 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 7 | $119.11 | |
| Bayer Healthcare Pharmaceuticals INC. | 6 | $103.36 | |
| Tandem Diabetes Care, INC. | 4 | $63.36 | |
| Corcept Therapeutics | 3 | $44.50 | |
| Abbvie INC. | 3 | $39.99 | |
| Chiesi USA, INC. | 2 | $39.86 | |
| Alexion Pharmaceuticals, INC. | 2 | $39.51 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,313
Patients
651
Total drug cost
$736,564
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 301 | 65 | $344,026 |
| Levothyroxine Sodium | Generic | 227 | 78 | $3,896 |
| Rosuvastatin Calcium | Generic | 210 | 68 | $3,754 |
| Trulicity (Dulaglutide) | Brand | 207 | 30 | $258,214 |
| Atorvastatin Calcium | Generic | 184 | 67 | $2,796 |
| Pioglitazone Hcl | Generic | 153 | 47 | $2,284 |
| Synthroid (Levothyroxine Sodium) | Brand | 148 | 40 | $18,170 |
| Glimepiride | Generic | 146 | 43 | $1,989 |
| Methimazole | Generic | 137 | 37 | $1,610 |
| Metformin Hcl | Generic | 120 | 39 | $1,649 |
Hospital affiliations
Frequently asked questions
What is Dr. James Edmondson's medical specialty?
Dr. James Edmondson practices Endocrinology, Diabetes & Metabolism Physician in Indianapolis, IN.
Where does Dr. James Edmondson practice?
Dr. James Edmondson practices at 100 Hospital Ln, Indianapolis, IN 462025112. Office phone: 3177457445.
What is Dr. James Edmondson's NPI?
Dr. James Edmondson's National Provider Identifier (NPI) is 1831154863, issued by NPPES.
Does Dr. James Edmondson accept Medicare assignment?
Yes. Dr. James Edmondson accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. James Edmondson commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Hemoglobin a1c level (HCPCS 83036). Source: CMS Medicare Physician & Other Practitioners file.